Pathogenesis and Surgical Management of Common Geriatric Ophthalmic Disorders

  • Ray F. Gariano
  • Jayne N. Ge
  • Kathleen M. Stoessel


Visual loss is a leading cause of morbidity in elderly patients in industrialized and developing countries. Decreased visual acuity interferes with activities such as reading, driving, walking without assistance, and numerous daily tasks that allow employment and independent living. It has been estimated that in the United States 10% of persons over the age of 75 years have a visual disability, and 2.2% over age 65 years are legally blind (defined as acuity of 20/200 or worse in the better eye or visual field constriction to less than 20 degrees).1–4 Many cases of legal blindness are preventable with early detection and treatment.5,6


Diabetic Retinopathy Retinal Detachment Cataract Surgery Retinal Nerve Fiber Layer Aqueous Humor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Friedenwald JS. The eye. In: Cowdry EV (ed) The Problems of Aging, 2nd ed. Williams & Wilkins: Baltimore, 1942:535.Google Scholar
  2. 2.
    Caird FT, Wiliamson J. The Eye and Its Disorders in the Elderly. Wright: Bristol, 1986.Google Scholar
  3. 3.
    US Department of Health and Human Services. Current Estimates from the National Health Interview Survey: United States. US Public Health Service Publ. No. 86–1582, Series 10, No. 154. OHHS: Hyattsville, MD, 1983.Google Scholar
  4. 4.
    Podgor MJ, Leske MC, Ederer F. Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retinopathy. Am J Epidemiol 1983;118:206–212.PubMedGoogle Scholar
  5. 5.
    Butler RN, Faye EE, Guazzo E, Kupfer C. Keeping an eye on vision: primary care of age-related ocular disease: part 1. Geriatrics 1997;52(8):30–41.PubMedGoogle Scholar
  6. 6.
    Rosenberg LF, Glaucoma: Early detection and therapy for prevention of vision loss. Am Fam Physician 1995;52: 2289–2298.PubMedGoogle Scholar
  7. 7.
    Wong DH. Regional anesthesia for intraocular surgery. Can J Anaesth 1993;40:645–657.Google Scholar
  8. 8.
    Kattan HM, Flynn HW, Pflugfelder SC, Robertson C, Forster RK. Nosocomial endophthalmitis survey: current incidence of infection after intraocular surgery. Ophthalmology 1991;98:227–238.PubMedGoogle Scholar
  9. 9.
    Troll GF Regional ophthalmic anesthesia: safe techniques and avoidance of complications. J Clin Anesth 1995; 7:163–172.PubMedCrossRefGoogle Scholar
  10. 10.
    Lindquist TD, Lindstrom R. Ophthalmic Surgery. Loose-leaf and Update Service. Mosby: St. Louis, 1990.Google Scholar
  11. 11.
    Buckley EG, Shields MB. Atlas of Ophthalmic Surgery, vol III: Strabismus and Glaucoma. Mosby-Year Book: St. Louis, 1995.Google Scholar
  12. 12.
    Pastorek N. Upper-lid blepharoplasty. Facial Plast Surg 1996;12:157–169.PubMedCrossRefGoogle Scholar
  13. 13.
    Berlin AJ, Vestal KP. Levator aponeurosis surgery: a retrospective review. Ophthalmology 1989;96:1033–1036.PubMedGoogle Scholar
  14. 14.
    Koch RJ, Troell RF, Goode RL. Contemporary management of the aging brow and forehead. Laryngoscope 1997; 107:710–715.PubMedCrossRefGoogle Scholar
  15. 15.
    Dresner SC, Karesh JW. Transconjunctival entropion repair. Arch Ophthalmol 1993;111:1144–1148.PubMedCrossRefGoogle Scholar
  16. 16.
    Anderson RL, Gord DD. The tarsal strip procedure. Arch Ophthalmol 1979;97:2192–2196.PubMedCrossRefGoogle Scholar
  17. 17.
    Mauriello JA Jr, Dhillon S, Leone T, Pakeman B, Mostafavi R, Yepez X. Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years. Br J Ophthalmol 1996;80:1073–1076.PubMedCrossRefGoogle Scholar
  18. 18.
    Cole H. Botulinum toxin may help blepharospasm sufferers. JAMA 1985;254:1688–1690.PubMedCrossRefGoogle Scholar
  19. 19.
    Kass LG, Hornblass A. Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol 1989;33:477–490.PubMedCrossRefGoogle Scholar
  20. 20.
    Margo CE, Waltz K. Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol 1993;38:169–192.PubMedCrossRefGoogle Scholar
  21. 21.
    Leshin B, Yeatts P. Management of periocular basal cell carcinoma: Mohs’ micrographic surgery versus radiotherapy. Surv Ophthalmol 1993;38:193–212.PubMedCrossRefGoogle Scholar
  22. 22.
    Muenzier WS. The dry eye: a working outline of etiology, symptoms, diagnosis, and treatment. Geriatr Ophthalmol 1986;2:219–223.Google Scholar
  23. 23.
    Price EJ, Venables PJ. The etiopathogenesis of Sjogren’s syndrome. Semin Arthritis Rheum 1995;25:117–133.PubMedCrossRefGoogle Scholar
  24. 24.
    Anonymous. Punctal occlusion for the dry eye: three-year revision; American Academy of Ophthalmology. Ophthalmology 1997;104:1521–1524.CrossRefGoogle Scholar
  25. 25.
    Tarbet KJ, Custer PL. External dacryocystorhinostomy: surgical success, patient satisfaction, and economic cost. Ophthalmology 1995;102:1065–1070.PubMedGoogle Scholar
  26. 26.
    Wigham CG, Hodson SA. Physiological changes in the cornea of the ageing eye. Eye 1987;1:190–196.PubMedCrossRefGoogle Scholar
  27. 27.
    Morrison LK, Waltman SR. Management of Pseudophakic bullous keratopathy. Ophthalmic Surg 1989;20:105–210.Google Scholar
  28. 28.
    Boruchoff SA. Penetrating keratoplasy In: Albert DM, Jakobiec FA (eds) Principles and Practice of Ophthalmology, vol I. Saunders: Philadelphia, 1994:325–342.Google Scholar
  29. 29.
    Gillum W. Mechanisms of accommodation in vertebrates. Ophthalmic Semin 1976;1:253–286.PubMedGoogle Scholar
  30. 30.
    Duane A. Normal values of the accommodation at all ages. JAMA 1912;59:1010–1013.CrossRefGoogle Scholar
  31. 31.
    Javitt JC, Wang F, Trentacost DJ, Rowe M, Tarantino N. Outcomes of cataract extraction with multifocal intraocular lens implantation: functional status and quality of life. Ophthalmology 1997;104:589–599.PubMedCrossRefGoogle Scholar
  32. 32.
    Kupfer C, Underwood B, Gillen T. Leading causes of visual impairment worldwide. In: Albert DM, Jakobiec FA (eds) Principles and Practice of Ophthalmology: Basic Sciences. Saunders: Philadelphia, 1994:1249–1255.Google Scholar
  33. 33.
    Klein BE, Klein R, Moss SE. Incident cataract surgery: the Beaver Dam eye study. Ophthalmology 1997;104:573–580.PubMedCrossRefGoogle Scholar
  34. 34.
    Kahn HA, Leibowitz HM, Ganley JP, et al. The Framing-ham eye study: outline and major prevalence findings. Am J Epidemiol 1977;106:117.Google Scholar
  35. 35.
    Benedek GB. Cataract as a protein condensation disease. Invest Ophthalmol Vis Sci 1997;38:1911–1922.PubMedGoogle Scholar
  36. 36.
    Lee PP, Hiborne L, McDonald L, et al. Documentation patterns before cataract surgery at ten academic centers. Ophthalmology 1996;103:1179–1183.PubMedGoogle Scholar
  37. 37.
    Jaffe GJ, Burton TC, Kuhn E, Prescott A, Hartz A. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol 1992;114: 448–456.PubMedGoogle Scholar
  38. 38.
    Steinberg EP, Javitt JC, Sharkey PD, et al. The content and cost of cataract surgery. Arch Ophthalmol 1993;111:1041–1049.PubMedCrossRefGoogle Scholar
  39. 39.
    Curbow B, Legro MW, Brenner MH. The influence of patient-related variables in the timing of cataract extraction. Am J Ophthalmol 1993;115:614–622.PubMedGoogle Scholar
  40. 40.
    Rutkow IM. Surgical operations in the United States: then (1983) and now (1994). Arch Surg 1997;132:983–990.PubMedCrossRefGoogle Scholar
  41. 41.
    Desai P. The National Cataract Surgery Survey. II. Clinical outcomes. Eye 1993;7:489–494.PubMedCrossRefGoogle Scholar
  42. 42.
    Fine IH. The chip and flip phacoemulsification technique. J Cataract Refract Surg 1991;17:366–371.PubMedCrossRefGoogle Scholar
  43. 43.
    Gimbel HV. Divide and conquer nucleofractis phacoemulsification: development and variations. J Cataract Refract Surg 1991;17:281–291.PubMedCrossRefGoogle Scholar
  44. 44.
    Javitt JC, Vitale S, Canner JK, et al. National outcomes of cataract surgery: endophthalmitis following inpatient surgery. Arch Ophthalmol 1991;109:1085–1089.PubMedCrossRefGoogle Scholar
  45. 45.
    Tezel G, Kolker AE, Kass MA, Wax MB. Comparative results of combined procedures for glaucoma and cataract. I. Extracapsular cataract extraction versus phacoemulsification and foldable versus rigid intraocular lenses. Ophthalmic Surg Laser 1997;28:539–550.Google Scholar
  46. 46.
    Apple DJ, Solomon KD, Tetz MR, et al. Posterior capsule opacification. Surv Ophthalmol 1992;37(2):73–116.PubMedCrossRefGoogle Scholar
  47. 47.
    Steinberg EP, Tielsch JM, Schein OD, et al. National study of cataract surgery outcomes: variation in 4-month postoperative outcomes as reflected in multiple outcome measures. Ophthalmology 1994;101:1131–1140.PubMedGoogle Scholar
  48. 48.
    Kahn HA, Leibowitz HM, Ganley JB. Framingham eye study. I. Outline and major prevalence findings. Am J Epidemiol 1977;106:17.PubMedGoogle Scholar
  49. 49.
    Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Lavitt J. Racial variations in the prevalence of primary open-angle glaucoma. JAMA 1991;266:369–374.PubMedCrossRefGoogle Scholar
  50. 50.
    Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996;80:389–393.PubMedCrossRefGoogle Scholar
  51. 51.
    Millard CB, Tripathi BJ, Tripathi RC. Age-related changes in protein profiles of the normal human trabecular mesh-work. Exp Eye Res 1987;45:623–631.PubMedCrossRefGoogle Scholar
  52. 52.
    Albon J, Karwatowski WS, Avery N, Easty DL, Duance VC. Changes in the collagenous matrix of the aging human lamina cribrosa. Br J Ophthalmol 1995;79:368–375.PubMedCrossRefGoogle Scholar
  53. 53.
    Colton T, Ederer F. The distribution of intraocular pressures in the population. Surv Ophthalmol 1980;25: 123–129.PubMedCrossRefGoogle Scholar
  54. 54.
    Butler RN, Faye EE, Guazzo E, Kupfer C. Keeping an eye on vision: new tools to preserve sight and quality of life; a roundtable discussion, part 2. Geriatrics 1997;52(9):48–50, 53–56.PubMedGoogle Scholar
  55. 55.
    Quigley HA. Reappraising the risk and benefits of aggressive glaucoma therapy. Ophthalmology 1997;104: 1985–1986.PubMedCrossRefGoogle Scholar
  56. 56.
    Roy H, Tindall R. An update on the use of drugs for common eye problems in older patients. Geriatrics 1991;46(11):51–54, 57–60.PubMedGoogle Scholar
  57. 57.
    Prakash UB, Rosenow EC III. Pulmonary complications from ophthalmic preparations. Mayo Clin Proc 1990;65: 521–529.PubMedCrossRefGoogle Scholar
  58. 58.
    Glaucoma Laser Trial Research Group: The glaucoma laser trial and glaucoma laser trial follow-up study. 7. Results. Am J Ophthalmol 1995;120:718–731.Google Scholar
  59. 59.
    Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J. Outcomes of trabeculectomy for primary open-angle glaucoma. Ophthalmology 1995;102:1760–1769.PubMedGoogle Scholar
  60. 60.
    Fluorouracil Filtering Surgery Study Group. Three-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 1993;115:82–92.Google Scholar
  61. 61.
    Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology 1991;98:317–321.PubMedGoogle Scholar
  62. 62.
    Price FW Jr, Wellemeyer M. Long-term results of Molteno implants. Ophthalmic Surg 1995;26:130–135.PubMedGoogle Scholar
  63. 63.
    Mastrobattista JM, Luntz M. Ciliary body ablation: where are we and how did we get here? Surv Ophthalmol 1996; 41:193–213.PubMedCrossRefGoogle Scholar
  64. 64.
    Leibowitz HM, Krueger DE, Maunder LR, et al. Framing-ham eye study monograph. Surv Ophthalmol 1980;24 (suppl):335–610.PubMedCrossRefGoogle Scholar
  65. 65.
    Green WR, Key SN. Senile macular degeneration: a histopathological study. Trans Am Ophthalmol Soc 1977; 75:180–254.PubMedGoogle Scholar
  66. 66.
    Mainster MA. Light and macular degeneration: a biophysical and clinical perspective. Eye 1987;1:304–310.PubMedCrossRefGoogle Scholar
  67. 67.
    Mares-Perlman JA, Klein R, Klein BE, et al. Association of zinc and antioxidant nutrients with age-related maculopa-thy. Arch Ophthalmol 1996;114:991–997.PubMedCrossRefGoogle Scholar
  68. 68.
    Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: three-year results from randomized trials. Arch Ophthalmol 1986;104:694–701.CrossRefGoogle Scholar
  69. 69.
    Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: five-year results from randomized trials. Arch Ophthalmol 1991; 109:1109–1114.CrossRefGoogle Scholar
  70. 70.
    Moisseiev J, Alhalel A, Masuri R, Treister G. The impact of the macular photocoagulation study results on the treatment of exudative age-related macular degeneration. Arch Ophthalmol 1995;113:185–189.PubMedCrossRefGoogle Scholar
  71. 71.
    Yonemoto LT, Slater JD, Friedrichsen EJ, et al. Phase I/II study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: treatment techniques and preliminary results. Int J Radiat Oncol Biol Phys 1996;36: 867–871.PubMedCrossRefGoogle Scholar
  72. 72.
    Sakamoto T, Soriano D, Nassaralla J, et al. Effect of intra-vitreal administration of indomethacin on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 1995;113:222–226.PubMedCrossRefGoogle Scholar
  73. 73.
    Ibanez HE, Williams DF, Thomas MA, et al. Surgical management of submacular hemorrhage: a survey of 47 consecutive cases. Arch Ophthalmol 1995;113:62–69.PubMedCrossRefGoogle Scholar
  74. 74.
    Kaplan HJ, Tezel TH, Berger AS, Wolf ML, Del Priore LV. Human photoreceptor transplantation in retinitis pigmentosa: a safety study. Arch Ophthalmol 1997;115: 1168–1172.PubMedCrossRefGoogle Scholar
  75. 75.
    Haimann MH, Burton TC, Brown CK. Epidemiology of retinal detachment. Arch Ophthalmol 1982;100:289.PubMedCrossRefGoogle Scholar
  76. 76.
    Byer NE. Natural history of posterior vitreous detachment with early management as the premier line of defense against retinal detachment. Ophthalmology 1994;101: 1503–1513; discussion 1513–1514.PubMedGoogle Scholar
  77. 77.
    Byer NE. The natural history of asymptomatic retinal breaks. Ophthalmology 1982;89:1033–1039.PubMedGoogle Scholar
  78. 78.
    Scheie HG, Morse PH, Aminlari A. Incidence of retinal detachment following cataract extraction. Arch Ophthalmol 1973;89:293.PubMedCrossRefGoogle Scholar
  79. 79.
    Kramer SG, Benson WE. Prophylactic therapy of retinal breaks. Surv Ophthalmol 1977;22:41–47.PubMedCrossRefGoogle Scholar
  80. 80.
    McCuen BW, Azen SP, Stern W, et al. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: silicone study report 3. Retina 1993;13:279–284.PubMedCrossRefGoogle Scholar
  81. 81.
    Tornambe PE, Hilton GF. Pneumatic retinopexy: a multi-center randomized controlled clinical trial comparing pneumatic retinopexy with scleral buckling: the Retinal Detachment Study Group. Ophthalmology 1989;96: 772–783.PubMedGoogle Scholar
  82. 82.
    McAllister IL, Meyers SM, Zegarra H, Gutman FA, Zakov ZN, Beck GJ. Comparison of pneumatic retinopexy with alternative surgical techniques. Ophthalmology 1988;95: 877–883.PubMedGoogle Scholar
  83. 83.
    Escoffery RF, Olk RJ, Grand MG, Boniuk I. Vitrectomy without scleral buckling for primary rhegmatogenous retinal detachment. Am J Ophthalmol 1985;99:275–281.PubMedGoogle Scholar
  84. 84.
    Hanneken A, Michels RG. Vitrectomy and scleral buckling methods for proliferative vitreoretinopathy. Ophthalmology 1988;95:865–869.PubMedGoogle Scholar
  85. 85.
    Berger AS, Cheng CK, Pearson PA, et al. Intravitreal sustained release corticosteroid-5-fluorouracil conjugate in the treatment of experimental proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1996;37:2318–2325.PubMedGoogle Scholar
  86. 86.
    Gariano RF, Assil KK, Wiley CA, Munguia D, Weinreb RN, Freeman WR. Retinal toxicity of the antimetabolite 5-fluorouridine 5’-monophosphate administered intravitre-ally using multivesicular liposomes. Retina 1994;14:75–80.PubMedCrossRefGoogle Scholar
  87. 87.
    Palmberg P, Smith M, Waltman S, et al. The natural history of retinopathy in insulin-dependent juvenile-onset diabetes. Ophthalmology 1981;88:613–618.PubMedGoogle Scholar
  88. 88.
    Ohkubo Y, Kishikawa H, Araki E. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103–117.PubMedCrossRefGoogle Scholar
  89. 89.
    Frank RN. On the pathogenesis of diabetic retinopathy: a 1990 update. Ophthalmology 1991;98:586–593.PubMedGoogle Scholar
  90. 90.
    Cogan DG, Toussaint D, Kuwabara T. Retinal vascular patterns. IV Diabetic retinopathy. Arch Ophthalmol 1961; 66:366–378.PubMedCrossRefGoogle Scholar
  91. 91.
    Anonymous. Early photocoagulation for diabetic retinopathy: ETDRS report number 9: Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991; 98(suppl 5):766–785.Google Scholar
  92. 92.
    Anonymous. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema: early treatment diabetic retinopathy study report number 2; Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1987;94:761–774.Google Scholar
  93. 93.
    Danis RP, Bingaman DP, Jirousek M, Yang Y. Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKC beta inhibition with LY333531. Invest Ophthalmol Vis Sci 1998;39:171–179.PubMedGoogle Scholar
  94. 94.
    Anonymous. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: four-year results of a randomized trial: diabetic retinopathy vitrectomy; study report 5. Arch Ophthalmol 1990;108:958–964.CrossRefGoogle Scholar
  95. 95.
    Ho T, Smiddy WE, Flynn HW. Vitrectomy in the management of diabetic eye disease. Surv Ophthalmol 1992;37: 190–202.PubMedCrossRefGoogle Scholar
  96. 96.
    Anonymous. Results of the endophthalmitis vitrectomy study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis; Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 1997;113:1479–1496.Google Scholar
  97. 97.
    Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 eyes with uveal metastases. Ophthalmology 1997;104:1265–1276.PubMedCrossRefGoogle Scholar
  98. 98.
    Rudoler SB, Corn BW, Shields CL, et al. External beam irradiation for choroid metastases: identification of factors predisposing to long-term sequelae. Int J Rad Oncol, Biol, Physics 1997;38:251–256.Google Scholar
  99. 99.
    Scotto J, Fraumeni JF, Lee JAH. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 1976;56:489–491.PubMedGoogle Scholar
  100. 100.
    Shields JA, Shields CL. Current management of posterior uveal melanoma. Mayo Clin Proc 1993;68:1196–1200.PubMedCrossRefGoogle Scholar
  101. 101.
    Freeman LN, Schachat AP, Knox DL, Michels RG, Green WR. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 1987;94:1631–1639.PubMedGoogle Scholar
  102. 102.
    Margolis L, Fraser R, Lichter A, Char DH. The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer 1980;45:688–692.PubMedCrossRefGoogle Scholar
  103. 103.
    Neupert JR, Brubaker RF, Kearns TP, Sundt TM. Rapid resolution of venous stasis retinopathy after carotid endarterectomy. Am J Ophthalmol 1976;81:600–602.PubMedGoogle Scholar
  104. 104.
    Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33: 1122–1128.PubMedCrossRefGoogle Scholar
  105. 105.
    Hayreh SS. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997;123: 285–296.PubMedGoogle Scholar
  106. 106.
    Stevens RJ, Hughes R. The aetiopathogenesis of giant cell arteritis. Br J Rheumatol 1995;34:960–965.PubMedCrossRefGoogle Scholar
  107. 107.
    Magram I, Schlossman A. Strabismus in patients over the age of 60 years. J Pediatr Ophthalmol Strabismus 1991;28:28–31.Google Scholar
  108. 108.
    Warren M. Providing low vision rehabilitation services with occupational therapy and ophthalmology: a program description. Am J Occup Ther 1995;49:877–883.PubMedCrossRefGoogle Scholar
  109. 109.
    Swanson MW, Brock J, Houston R. Older Alabamians System of Information and Services (OASIS): a model title VII chapter 2 low vision rehabilitation program. J Am Optom Assoc 1995;66:357–361.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Ray F. Gariano
  • Jayne N. Ge
  • Kathleen M. Stoessel

There are no affiliations available

Personalised recommendations